Introduction to the National SBIRT ATTC – Who Are We and What Does That Mean to You?

Introduction to the National SBIRT ATTC – Who are we and What does that mean to you? –

FDA Rejection of Buprenorphine Implant a Rare Reversal of Committee Decision

Filed under: buprenorphine treatment

Probuphine is a long-acting implant that delivers buprenorphine, an FDA-approved medicine for the treatment of opioid dependence in adult patients. Officials at Titan Pharmaceuticals, the developer of the drug, said they were “extremely surprised and …
Read more on Pain Medicine News

Orexo gets FDA OK for opioid dependence drug

Filed under: buprenorphine treatment

The US Food and Drug Administration has approved Zubsolv, a once-daily sublingual formulation of Reckitt Benckiser's Suboxone (buprenorphine/naloxone) which currently dominates the market. It is indicated for use as maintenance treatment for people …
Read more on PharmaTimes

OREXO AB : FDA Approves Zubsolv™ for the Maintenance Treatment of Opioid …

Filed under: buprenorphine treatment

Zubsolv is a once-daily, sublingual tablet with an advanced formulation of buprenorphine and naloxone that fully dissolves within minutes. Compared with other buprenorphine/naloxone treatments, Zubsolv has higher. bioavailability, faster dissolve time …
Read more on 4-traders (press release)